| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 45 | 0 | 0 | 0 | 6.068 | 5.753 | 4.873 | 15.338 | 22.407 |
| Total Income - EUR | - | 45 | 0 | 0 | 3.902 | 28.715 | 63.982 | 33.601 | 25.371 | 33.292 |
| Total Expenses - EUR | - | 20 | 1.982 | 1.360 | 600 | 28.854 | 67.551 | 41.499 | 28.511 | 31.016 |
| Gross Profit/Loss - EUR | - | 24 | -1.982 | -1.360 | 3.302 | -139 | -3.569 | -7.898 | -3.140 | 2.275 |
| Net Profit/Loss - EUR | - | 23 | -1.982 | -1.360 | 3.302 | -200 | -3.627 | -8.234 | -3.393 | 1.942 |
| Employees | - | 0 | 1 | 1 | 1 | 5 | 5 | 0 | 3 | 3 |
Check the financial reports for the company - Novamed Research Center Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 69 | 40 | 10 | 0 | 0 | 79.350 | 68.617 | 57.464 | 46.258 |
| Current Assets | - | 1.113 | 441 | 614 | 123 | 170.667 | 51.438 | 14.192 | 483 | 51 |
| Inventories | - | 10 | 163 | 160 | 157 | 330 | 313 | 314 | 313 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 164.699 | 35.880 | 11.473 | 23 | 0 |
| Cash | - | 1.103 | 278 | 454 | -34 | 5.639 | 15.245 | 2.405 | 147 | 51 |
| Shareholders Funds | - | 68 | -1.915 | -3.241 | 123 | 4.015 | 299 | -7.935 | -11.304 | -9.299 |
| Social Capital | - | 45 | 44 | 43 | 42 | 4.135 | 4.043 | 4.056 | 4.043 | 4.021 |
| Debts | - | 1.115 | 2.397 | 3.865 | 0 | 15.873 | 41.282 | 29.988 | 30.127 | 27.587 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 150.780 | 89.208 | 60.757 | 39.123 | 28.020 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Novamed Research Center Srl